Anna Kwiatkowska

Dr. Anna Kwiatkowska

Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GTGary Thomas
Gary Thomas
FCFrédéric Couture
Frédéric Couture
AKAnna Kwiatkowska
Anna Kwiatkowska
The spurious acquisition and optimization of a furin cleavage site in the SARS-CoV-2 spike protein is associated with increased viral transmission and disease, and has generated intense interest in the development and application of therapeutic furin inhibitors to thwart the COVID-19 pandemic. This review summarizes the seminal studies that informed current efforts to inhibit furin. These include the convergent efforts of endocrinologists, virologists, and yeast geneticists that, together, culminated in the discovery of furin. We describe the pioneering biochemical studies which led to the first furin inhibitors that were able to block the disease pathways which are broadly critical for pathogen virulence, tumor invasiveness, and atherosclerosis. We then summarize how these studies subsequently informed current strategies leading to the development of small-molecule furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases that rely on furin for their pathogenicity and progression.

11 January 2016 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
AKAnna Kwiatkowska
Anna Kwiatkowska
FCFrédéric Couture
Frédéric Couture
CLChristine Levesque
Christine Levesque
KLKévin Ly
Kévin Ly
SBSophie Beauchemin
Sophie Beauchemin
RDRobert Day
Robert Day

14 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AKAnna Kwiatkowska
Anna Kwiatkowska
FCFrédéric Couture
Frédéric Couture
SASamia Ait-Mohand
Samia Ait-Mohand
RDRoxane Desjardins
Roxane Desjardins
YDYves Dory
Yves Dory
RDRobert Day
Robert Day
The proprotein convertase PACE4 has been validated as a potential target to develop new therapeutic interventions in prostate cancer (PCa). So far, the most effective compound blocking the activity of this enzyme has been designed based on the structure of a small peptide Ac-LLLLRVKR-NH2 known as the Multi-Leu (ML) peptide. Optimization of this scaffold led to the synthesis of compound C23 (Ac-[DLeu]LLLRVK-amidinobenzylamide) with a potent in vivo inhibitory effect on the tumor growth. However, further developments of PACE4 inhibitors may require additional improvements to counter their rapid renal clearance and to increase their tumor targeting efficiency. Herein, we explored the transformation of the ML-peptide into an albumin-binding prodrug containing a tumor specific release mechanism based on the prostate-specific antigen. Our data confirms that intravenous treatment using the ML-peptide alone has little effect on tumor growth, whereas by using the ML-prodrug in LNCaP xenograft-bearing mice it was significantly reduced. Additionally, excellent in vivo stability and tumor-targeting efficiency was demonstrated using a radiolabelled version of this compound. Taken together, these results provide a solid foundation for further development of targeted PACE4 inhibition in PCa.

24 March 2017 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
IMIzabela Małuch
Izabela Małuch
CLChristine Levesque
Christine Levesque
AKAnna Kwiatkowska
Anna Kwiatkowska
FCFrédéric Couture
Frédéric Couture
KLKévin Ly
Kévin Ly
RDRobert Day
Robert Day

19 July 2017 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
VDVahid Dianati
Vahid Dianati
ASAzar Shamloo
Azar Shamloo
AKAnna Kwiatkowska
Anna Kwiatkowska
RDRoxane Desjardins
Roxane Desjardins
ASArmand Soldera
Armand Soldera
YDYves Dory
Yves Dory

5 February 2021 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MLMonika A. Lewandowska-Goch
Monika A. Lewandowska-Goch
AKAnna Kwiatkowska
Anna Kwiatkowska
TŁTeresa Łepek
Teresa Łepek
KLKévin Ly
Kévin Ly
PNPauline Navals
Pauline Navals
RDRobert Day
Robert Day